Erika Jones
Chief Accounting Officer
Black Diamond Therapeutics, Inc. (BDTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Erika Jones
Erika Jones is recorded as CFO and Chief Accounting Officer at Black Diamond Therapeutics, Inc. (BDTX). Black Diamond Therapeutics, Inc. reported in an 8-K filed October 7, 2024 that Erika Jones was appointed principal financial officer, effective October 7, 2024.
“In connection with the Separation, effective October 7, 2024, Erika Jones, the Company's Senior Vice President, Finance and Corporate Controller, and principal accounting officer, was appointed as principal financial officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-07–present
-
Current
2021-11-19–present
-
Black Diamond Therapeutics, Inc. (BDTX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Black Diamond Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark A. Velleca CEO
- Mark A. Velleca, M.D., Ph.D. CEO, Chairman
- Mark Velleca CEO
- Mark Velleca, M.D., Ph.D. CEO, Board Member
- Thomas Leggett CFO
- Brent Hatzis-Schoch COO
- Kapil Dhingra Board Member
- Prakash Raman, Ph.D. Board Member
- Robert A. Ingram Board Member
- Shannon Campbell Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.